HCA stock hits all-time high at 475.74 USD

Published 30/10/2025, 15:16
HCA stock hits all-time high at 475.74 USD

HCA Holdings Inc has reached a significant milestone, with its stock hitting an all-time high of 475.74 USD. According to InvestingPro data, the stock appears slightly overvalued compared to its Fair Value, with an RSI indicating overbought territory. This achievement underscores a robust performance over the past year, during which the company’s stock has appreciated by 30.84%, with an even more impressive 56.99% year-to-date return and 36.24% gain over the past six months. The healthcare giant’s impressive growth trajectory highlights its resilience and strong market position, attracting investor confidence and driving its stock price to new heights. With a substantial market capitalization of $110.68 billion and an "GREAT" overall financial health score from InvestingPro, this all-time high reflects the company’s successful strategies and operational efficiencies, setting a positive tone for its future prospects in the competitive healthcare sector. Discover comprehensive analysis in HCA’s Pro Research Report, available among 1,400+ US equities covered in-depth.

In other recent news, HCA Healthcare reported a robust third-quarter performance, with an adjusted EBITDA of $3,870 million, surpassing consensus estimates by approximately 12%. This strong performance has led to multiple analyst firms, including RBC Capital and KeyBanc, raising their price targets for HCA Healthcare to $482 and $475, respectively. RBC Capital highlighted the company’s better-than-expected core performance and contributions from state supplemental programs as reasons for the improved outlook. KeyBanc noted the positive impact of Medicaid Supplemental Directed Payments and stronger patient volumes on the third-quarter results. Additionally, Mizuho increased its price target to $505, citing a strong outlook despite potential challenges from the expiration of enhanced tax credits. Bernstein SocGen Group maintained a Market Perform rating with a price target of $417, acknowledging the company’s solid earnings results. In other developments, HCA Healthcare announced plans to offer senior notes, which may be used for general corporate purposes, including debt management. These recent developments reflect a positive sentiment among analysts regarding HCA Healthcare’s financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.